PULSE BIOSCIENCES, INC. — Director's Dealing 2021

Jan 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2021-01-08

Reporting Person: Zanganeh Maky (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-08	Common Stock	X	3000	$7.01	Acquired	355500	Direct
2021-01-19	Common Stock	X	307	$7.01	Acquired	107074	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-08	Warrant (right to buy)	$7.01	X	3000	Disposed	2025-06-15	Common Stock (3000)	Direct
2021-01-19	Warrant (right to buy)	$7.01	X	307	Disposed	2025-06-15	Common Stock (307)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27000	Indirect
Common Stock	14000	Indirect